.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
Healthtrust
Federal Trade Commission
Covington
Deloitte
Colorcon
Fish and Richardson
Baxter
US Army

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020161

« Back to Dashboard

NDA 020161 describes POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in two NDAs. It is available from two suppliers. Additional details are available on the POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER profile page.

The generic ingredient in POTASSIUM CHLORIDE 40MEQ IN PLASTIC CONTAINER is potassium chloride. There are two hundred and thirty-two drug master file entries for this compound. Seventy-five suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

Summary for 020161

Tradename:4
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020161

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161 NDA Hospira, Inc. 0409-7074 0409-7074-26 24 POUCH in 1 CASE (0409-7074-26) > 1 BAG in 1 POUCH > 100 mL in 1 BAG
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161 NDA Hospira, Inc. 0409-7075 0409-7075-14 24 POUCH in 1 CASE (0409-7075-14) > 1 BAG in 1 POUCH > 50 mL in 1 BAG

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength745MG/100ML
Approval Date:Nov 30, 1992TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1.49GM/100ML
Approval Date:Nov 30, 1992TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.24GM/100ML
Approval Date:Aug 11, 1998TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Deloitte
QuintilesIMS
Healthtrust
Covington
Medtronic
McKesson
Argus Health
Fuji
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot